Society for Endocrinology - a world-leading authority on hormones

Late Breaking Abstract submission is now open!

Submit abstract


Late Breaking Abstract Deadline: Monday 16 December 2024 (11:59pm GMT)

Late breaking submitters will be notified in January 2025 if they have been successful or not. 

Authors who submitted by the original deadline in October will be notified of the outcome of their submissions in early December

In an effort to be more environmentally friendly, the abstract list will be available to access online and not in a printed format. Ahead of the conference, you will be able to explore the complete collection of abstracts that are due to be presented at SfE BES 2025 in Endocrine Abstracts - a permanent, fully citable website that’s freely available to all without access restrictions

If you have any queries or issues with your submission, please contact the SfE BES 2025 Conference Team at [email protected]

Submitting your abstract

Sharing your work at SfE BES 2025 is a fantastic opportunity to get useful feedback and ideas to progress your work, as well as boosting your presentation and networking skills.

The Society for Endocrinology hopes to attract a wide range of endocrine related research to its conference to be shared and viewed by members of the field. Below you will find information about submitting your abstract, what will happen if you are successful and the abstract category list for SfE BES 2025:

  • Abstracts should be no longer than 300 words (including numbers, symbols and tables) and you must select one category from the below list. The use of figures or photographs are not permitted.
  • Abstracts are accepted on the understanding that the work has not been published or presented elsewhere, excluding associated Society for Endocrinology events.

Please note: you will be required to register to the submission system and then verify your email address before being able to submit your abstract.

Abstract category list for SfE BES 2025:

  • Adrenal & Cardiovascular
  • Bone & Calcium
  • Endocrine Cancer & Late Effects
  • Metabolism, Obesity & Diabetes
  • Neuroendocrinology & Pituitary
  • Nursing Practice
  • Reproductive Endocrinology
  • Thyroid
  • Innovation in teaching and assessment

Successful abstracts

  • Accepted abstracts are presented at the conference either as a poster or as an oral presentation. They will also be published online in Endocrine Abstracts – a fully open access and citable record of the abstracts presented at the conference. View the abstracts from SfE BES 2023
  • Any author failing to present an accepted abstract at this conference will automatically be excluded from submitting any future abstracts
  • The Programme Committee reserves the right of the final decision regarding acceptance of abstracts and the form of presentation
  • Abstracts are marked blind (anonymously). Please note that the reviewing panel for abstracts submitted to the nursing category predominantly includes nurses

Case reports 

Please note: case reports will only be accepted if they illustrate something significantly new or especially unusual in the clinical case load of the submitting endocrine unit.

Conditions of acceptance

Notification of acceptance or rejection of abstracts/cases will be sent to authors in November 2024 before the Early-bird registration deadline.

Detailed instructions concerning oral presentations and poster sessions will be emailed to qualifying authors with notification of acceptance.

Please note, abstracts that are accepted as poster presentation will need to be displayed on A0 portrait poster boards.

Prizes and awards

Early career presenting authors of accepted abstracts may be considered for a range of prizes and awards, which are presented during the conference and recognised at the SfEBES 2025 awards ceremony.